HER2-Targeted Multifunctional Silica Nanoparticles Specifically Enhance the Radiosensitivity of HER2-Overexpressing Breast Cancer Cells
Open accessThe DOI matches its Crossref record; 40 of the 43 references it cites were found in a registry or an index.
Abstract
We investigated the effects of targeted functionalized silica nanoparticles on the radiosensitivity of cancer cells. Better control of the local concentration of silica nanoparticles may facilitate their use as an adjuvant in conjunction with ionizing radiation to target cancer cells while preventing damage to normal cells. Hyperbranched polyamidoamine (PAMAM) was grafted onto the surface of amorphous silica nanoparticles to functionalize them. The PAMAM-coated silica nanoparticles (PCSNs) were then conjugated with fluorescent dyes. Anti-HER2 antibodies were covalently attached to the labeled PCSNs. The HER2-overexpressing SK-BR3 breast cancer cell line was incubated in medium containing the PCSN probes. After incubation; the cells were exposed to X-ray radiation. Cells were counted in all samples using cell proliferation assays; and apoptotic cells were detected. The cell survival results showed that the combination of the targeted PCSN probes and radiation reduced the survival rate of SK-BR3 cells to a greater extent than when either PCSN probes, PCSNs or radiation were applied individually. The results also showed an increase in apoptosis in the SK-BR3 cells that internalized the PCSN probes and were then irradiated. Based on these data, PCSN probes act as specific radiosensitizing agents for HER2-overexpressing cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A high degree of functionalization was reported across studies. Many nanoplatforms incorporated targeting ligands, therapeutic payloads, and microenvironment-responsive components [16,17,26,27,45,49,51,52,53].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [51]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Receptor-specific targeting approaches, including HER2-, CXCR4-, and folate-directed systems, were described in association with increased cellular uptake [20,24,29,51,54,55].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [51]
The cited source says what the claim attributes to it.
In the citing paper
“Receptor-specific targeting, including HER2-, CXCR4-, and folate-directed systems, was frequently described and associated with increased cellular uptake [20,24,29,49,51,55,70].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity
Stern, S. T., Adiseshaiah, P. P., & Crist, R. M. (2012) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-9-20 · Cited by 836
The lysosome: from waste bag to potential therapeutic target
Appelqvist, H., Wäster, P., Kågedal, K., & Öllinger, K. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt022 · Cited by 772
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma
Benezra, M., Penate-Medina, O., Zanzonico, P. B., Schaer, D., Ow, H., Burns, A., DeStanchina, E., Longo, V., Herz, E., Iyer, S., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45600 · Cited by 645 · cited 2×
“Furthermore, diagnostic probes composed of silica nanoparticles have already been approved for phase 1 human clinical trials, and the first clinical trial investigating modified fluorescent core-shell silica nanoparticles is in progress [13,14].”
BackgroundSalinomycin kills cancer stem cells by sequestering iron in lysosomes
Mai, T. T., Hamaï, A., Hienzsch, A., Cañeque, T., Müller, S., Wicinski, J., Cabaud, O., Leroy, C., David, A., Acevedo, V., et al. (2017) · Nature Chemistry · doi:10.1038/nchem.2778 · Cited by 612
Size‐Dependent Cytotoxicity of Monodisperse Silica Nanoparticles in Human Endothelial Cells
Napierska, D., Thomassen, L. C. J., Rabolli, V., Lison, D., Gonzalez, L., Kirsch‐Volders, M., Martens, J. A., & Hoet, P. H. (2009) · Small · doi:10.1002/smll.200800461 · Cited by 585 · cited 1×
“Generally, small silica nanoparticles exert greater effects than larger nanoparticles [20,23].”
BackgroundIn search of breast cancer culprits: suspecting the suspected and the unsuspected.
Subik, K., Lee, J.-F., Baxter, L., Strzepek, T., Costello, D., Crowley, P., Xing, L., Hung, M., Bonfiglio, T. A., Hicks, D. G., et al. (2008) · PubMed Central · Cited by 577
Subik, K., Lee, J.-F., Baxter, L., Strzepek, T., Costello, D., Crowley, P., Xing, L., Hung, M.-C., Bonfiglio, T., Hicks, D. G., et al. (2010) · Breast Cancer: Basic and Clinical Research · doi:10.1177/117822341000400004 · Cited by 573 · cited 1×
“The human breast cancer cell line SK-BR3 (HER2; 3+) [7] was obtained from the American Type Culture Collection (ATCC® number HTB-30TM).”
MethodChang, J.-S., Chang, K. L. B., Hwang, D.-F., & Kong, Z.-L. (2007) · Environmental Science & Technology · doi:10.1021/es062347t · Cited by 403 · cited 1×
“Moreover, a study comparing the cell damage caused by SiO2 nanoparticles revealed that there was no significant difference between 15-nm and 46-nm particles, and the cell damage they caused was dependent on the concentration and time [24].”
BackgroundKlapper, L. N., Waterman, H., Sela, M., & Yarden, Y. (2000) · PubMed · Cited by 351
Kwatra, D., Venugopal, A., & Anant, S. (2013) · Translational Cancer Research · doi:10.21037/1550 · Cited by 293 · cited 1×
“Densely packed metal particles selectively scatter and/or absorb high-energy gamma/X-ray radiation [3].”
BackgroundLysosomes as “Suicide Bags” in Cell Death: Myth or Reality?
Turk, B., & Turk, V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.023820 · Cited by 270
Effect of Silica Particle Size on Macrophage Inflammatory Responses
Kusaka, T., Nakayama, M., Nakamura, K., Ishimiya, M., Furusawa, E., & Ogasawara, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092634 · Cited by 228
Guo, C., Yang, M., Jing, L., Wang, J., Yu, Y., Li, Y., Duan, J., Zhou, X., Li, Y., & zwsun@ccmu.edu.cn, Z. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s112030 · Cited by 222 · cited 2×
“Although amorphous silica nanoparticle probes have previously been approved for human clinical trials, amorphous silica nanoparticles have been shown to cause cell damage [8,9].”
BackgroundLipsett, A., Barrett, S., Haruna, F., Mustian, K., & O'Donovan, A. (2017) · The Breast · doi:10.1016/j.breast.2017.02.002 · Cited by 217
Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model
Duan, J., Yu, Y., Li, Y., Yu, Y., & Sun, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.032 · Cited by 200
Evidence-based Estimates of the Demand for Radiotherapy
Delaney, G. P., & Barton, M. B. (2015) · Clinical Oncology · doi:10.1016/j.clon.2014.10.005 · Cited by 199 · cited 1×
“Nearly half of cancer patients undergo radiotherapy to cure their disease [1,2].”
BackgroundBiologic Basis for Combining Drugs With Radiation
WILSON, G., BENTZEN, S., & HARARI, P. (2006) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.08.001 · Cited by 198 · cited 2×
“strategy—epidermal growth factor receptor (EGFR) combined with HER2 [5]—has been introduced, it is necessary to identify more effective radiosensitizers to increase the efficiency of radiotherapy and to reduce radiation damage to surrounding normal tissues.”
BackgroundLee, S., Yun, H.-S., & Kim, S.-H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.042 · Cited by 182
Size-dependent cytotoxicity of amorphous silica nanoparticles in human hepatoma HepG2 cells
Li, Y., Sun, L., Jin, M., Du, Z., Liu, X., Guo, C., Li, Y., Huang, P., & Sun, Z. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.05.003 · Cited by 180
Bradbury, M. S., Phillips, E., Montero, P. H., Cheal, S. M., Stambuk, H., Durack, J. C., Sofocleous, C. T., Meester, R. J. C., Wiesner, U., & Patel, S. (2013) · Integrative Biology · doi:10.1039/c2ib20174g · Cited by 174 · cited 1×
“Furthermore, diagnostic probes composed of silica nanoparticles have already been approved for phase 1 human clinical trials, and the first clinical trial investigating modified fluorescent core-shell silica nanoparticles is in progress [13,14].”
BackgroundYuan, Y., Liu, C., Lu, J., Tang, W., Gan, Q., Zhou, H., Qian, J., & Lu, X. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24005 · Cited by 168
Molecular Elucidation of Biological Response to Mesoporous Silica Nanoparticles in Vitro and in Vivo
Chou, C., Chen, W., Hung, Y., & Mou, C. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b05359 · Cited by 111 · cited 1×
“It is reported that internalized mesoporous silica nanoparticles can release reactive oxygen species [17].”
BackgroundAriano, P., Zamburlin, P., Gilardino, A., Mortera, R., Onida, B., Tomatis, M., Ghiazza, M., Fubini, B., & Lovisolo, D. (2011) · Small · doi:10.1002/smll.201002287 · Cited by 104
Radiation-induced cell death: importance of lysosomal destabilization
Persson, H. L., Kurz, T., Eaton, J. W., & Brunk, U. T. (2005) · Biochemical Journal · doi:10.1042/bj20050271 · Cited by 95
Zhou, S., Wu, D., Yin, X., Jin, X., Zhang, X., Zheng, S., Wang, C., & Liu, Y.-W. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0492-6 · Cited by 84 · cited 1×
“It is well known that the inhalation of crystalline silica nanoparticles can cause silicosis, bronchitis or cancer, and high concentrations of silica nanoparticles are toxic [12,13], which are important factors that should be considered before use.”
BackgroundHER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb
Shukla, R., Thomas, T. P., Desai, A. M., Kotlyar, A., Park, S. J., & Baker Jr, J. R. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/29/295102 · Cited by 82 · cited 1×
“It has been reported that trastuzumab, when combined with dendrimers, traffics to and localizes within lysosomes [39,40].”
BackgroundTsubokawa, N. (2007) · Polymer Journal · doi:10.1295/polymj.pj2007035 · Cited by 76 · cited 1×
“Hyper-branched PAMAM (generation 3) was grafted onto the surface of synthetic amorphous silica nanoparticles (Aerosil 200, Nippon Aerosil, Tokyo, Japan) (Figure 13), resulting in a particle size of 20–50 nm, as previously reported [6].”
MethodSelf-citationThe Effect of Silica Nanoparticles on Human Corneal Epithelial Cells
Park, J.-H., Jeong, H., Hong, J., Chang, M., Kim, M., Chuck, R. S. H., Lee, J. K., & Park, C.-Y. (2016) · Scientific Reports · doi:10.1038/srep37762 · Cited by 74 · cited 2×
“However, 50-, 100- and 150-nm-sized silica nanoparticles were not shown to induce significant effects [23].”
BackgroundBreznan, D., Das, D. D., O’Brien, J. S., MacKinnon‐Roy, C., Nimesh, S., Vuong, N. Q., Bernatchez, S., DeSilva, N., Hill, M., Kumarathasan, P., et al. (2017) · Nanotoxicology · doi:10.1080/17435390.2017.1287313 · Cited by 67 · cited 1×
“Although amorphous silica nanoparticle probes have previously been approved for human clinical trials, amorphous silica nanoparticles have been shown to cause cell damage [8,9].”
BackgroundMiyano, T., Wijagkanalan, W., Kawakami, S., Yamashita, F., & Hashida, M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100105c · Cited by 64 · cited 1×
“It has been reported that trastuzumab, when combined with dendrimers, traffics to and localizes within lysosomes [39,40].”
BackgroundIntestinal absorption and biological effects of orally administered amorphous silica particles
Yoshida, T., Yoshioka, Y., Takahashi, H., Misato, K., Mori, T., Hirai, T., Nagano, K., Abe, Y., Mukai, Y., Kamada, H., et al. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-532 · Cited by 59
Lambert, O., Poussard, S., Décossas, M., Bihan, O. L., Mornet, S., & Naudin, G. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s74158 · Cited by 44
Yamaguchi, H., Tsuchimochi, M., Hayama, K., Kawase, T., & Tsubokawa, N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071086 · Cited by 41
Self-citationTsuchimochi, M., Hayama, K., Toyama, M., Sasagawa, I., & Tsubokawa, N. (2013) · EJNMMI Research · doi:10.1186/2191-219x-3-33 · Cited by 36 · cited 3×
“Moreover, PCSN probes may have a dual imaging and radiosensitizing functionality against their specific target cells, as suggested by previous reports using PAMAM silica nanoparticles as dual imaging probes [18,19].”
BackgroundMethodSelf-citationPotential for low-value palliative care of patients with recurrent head and neck cancer
Nilsen, M. L., & Johnson, J. T. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30260-7 · Cited by 36
Endocytic Trafficking of Silica Nanoparticles in A Cell Line Derived From The Organ of Corti
Pritz, C. O., Bitsche, M., Salvenmoser, W., Dudás, J., Schrott‐Fischer, A., & Glueckert, R. (2013) · Nanomedicine · doi:10.2217/nnm.12.91 · Cited by 22
Analysis of Skin Permeability and Toxicological Properties of Amorphous Silica Particles
Matsuo, K., Hirobe, S., Okada, N., & Nakagawa, S. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00258 · Cited by 18 · cited 1×
“Amorphous silica nanomaterials are generally thought to be safe and nontoxic [15,16].”
BackgroundYang, Y., Wang, A., Wei, Q., Schlesener, C., Haag, R., Li, Q., & Li, J. (2016) · ChemistryOpen · doi:10.1002/open.201600072 · Cited by 13
Radiosensitizing Silica Nanoparticles Encapsulating Docetaxel for Treatment of Prostate Cancer
Belz, J., Castilla‐Ojo, N., Sridhar, S., & Kumar, R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6646-2_26 · Cited by 12
Cited by
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
Vallet-Regí, M., Schüth, F., Lozano, D., Colilla, M., & Manzano, M. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00659b · Cited by 507
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: An update
Castillo, R. R., Lozano, D., González, B., Manzano, M., Izquierdo-Barba, I., & Vallet-Regí, M. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1598375 · Cited by 197
“MSNs: sensitizing agent for radiotherapy [43].”
Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment
Isa, E. D. M., Ahmad, H., Rahman, M. B. A., & Gill, M. R. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020152 · Cited by 140
Gisbert-Garzarán, M., & Vallet‐Regí, M. (2020) · Nanomaterials · doi:10.3390/nano10050916 · Cited by 89
Mesoporous silica nanoparticles as a versatile nanocarrier for cancer treatment: A review
Taleghani, A. S., Nakhjiri, A. T., Khakzad, M. J., Rezayat, S. M., Ebrahimnejad, P., Heydarinasab, A., Akbarzadeh, A., & Marjani, A. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.115417 · Cited by 79
Metadata
- Authors
- Yamaguchi, H., Hayama, K., Sasagawa, I., Okada, Y., Kawase, T., Tsubokawa, N., & Tsuchimochi, M.
- Affiliations
- Nippon Dental University (JP)
- Niigata University (JP)
- Corresponding author
- Tsuchimochi, Makoto
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-03-19
- Volume
- 19
- Issue
- 3
- Pages
- 908
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5877769
- OpenAlex
- W2790863426
- Cited by
- 30
- References
- 43
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 5 · 2020: 4 · 2019: 1
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (23592783, 15K11303)
- Topics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- HER2, silica nanoparticles, radiosensitization, breast cancer, PAMAM, antibody-conjugated nanoparticles, targeted drug delivery, SK-BR-3 cells, apoptosis, X-rays, fluorescent dye labeling, nanoparticle uptake
- MeSH terms
- Breast Neoplasms, Cell Nucleus, Cell Survival, Female, Fluorescence, Humans, Lysosomes, Particle Size, Polyamines, Radiation Tolerance, Silicon Dioxide, Erb-b2 Receptor Tyrosine Kinases, Cell Line, Tumor, Cell Proliferation, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.